Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 3/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19100379 | 1.00 | MMP2 (0.52) | MMP2MMP9NAALAD2ACECPB2 | |
| SCHEMBL21461809 | 0.95 | HRH1 (0.49) | MMP2MMP9NAALAD2ACECPB2 | |
| SCHEMBL16207519 | 0.95 | HRH1 (0.49) | MMP2MMP9NAALAD2ACECPB2 | |
| SCHEMBL29017599 | 0.86 | MMP2 (0.53) | MMP2MMP9ACECPB2FOLH1 | |
| SCHEMBL8249158 | 0.83 | MME (0.53) | NAALAD2ACECA2 | |
| SCHEMBL5869451 | 0.83 | MME (0.53) | NAALAD2ACECA2 | |
| SCHEMBL18668639 | 0.80 | MMP2 (0.48) | MMP2MMP9ACECPB2FOLH1 | |
| SCHEMBL7750537 | 0.80 | NAALAD2 (0.70) | MMP9NAALAD2FOLH1 | |
| SCHEMBL16599215 | 0.79 | MMP2 (0.50) | MMP2MMP9ACECPB2FOLH1 | |
| SCHEMBL11125240 | 0.79 | C3AR1 (0.48) | NAALAD2FOLH1PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220146518-A1 | TAG FOR LABELING BIOMOLECULES | SHANGHAI POLARIS BIOLOGY CO., LTD. (CN) | 2022-05-12 | — | — | US | disclosed |
| WO-2020228734-A1 | A TAG FOR LABELING BIOMOLECULES | SHANGHAI POLARIS BIOLOGY CO., LTD. (CN) | 2020-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220146518-A1 | TAG FOR LABELING BIOMOLECULES | BTD, DNPEP, ALB | MMP2 2951/4885MMP9 3635/4885NAALAD2 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.